Fig. 3
From: Clinical spectrum, genetics and management insights of PAX2-related disorder in nine children
Periodic follow-up of eGFR values in patients treated with ACEIs. A Patient 1 treated with Fosinopril for 5.2 years; B Patient 4 treated with Fosinopril for 3.0 years; C Patient 6 treated with Fosinopril for 0.5 years; D Patient 8 treated with Captopril for 1.0 year followed by discontinuation for 1.5 years; E Patient 9 treated with Enalapril for 1.2 years. Arrows below the horizontal axis indicate the duration of medication administration and follow-up period